Maharani Maharani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maharani Maharani has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Sutrisno Sutrisno
Department of Obstetrics and Gynecology/Midwifery Master Program, Faculty of Medicine, Universitas Brawijaya / Saiful Anwar Hospital / Malang Reproductive Training Center, Malang, Indonesia
7 shared publications Sutrisno Sutrisno
Department of Obstetrics and Gynecology Faculty of Medicine University of Brawijaya Saiful Anwar General Hospital Malang East Java Indonesia ub.ac.id
4 shared publicationsCut Yuniwati
3 shared publications- Ita Susanti
Stikes Medika Nurul Islam, Aceh, Indonesia
3 shared publications Lia Lajuna
2 shared publications- Lia Lajuna
Jurusan Kebidanan Poltekkes Kemenkes Aceh
2 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 5 (2) , 146-155
Effectiveness of the SIMPOL Web-Based Educational Intervention for Village Midwives in Improving Polio Immunization Coverage: A Quasi-Experimental Study
Introduction: Polio is a disease caused by the enterovirus (poliovirus) that attacks the brain's nervous system, causing paralysis in children. Although Indonesia has been a polio-free country since 2014, vigilance against the re-emergence of polio virus cases must still be increased by increasing polio immunization coverage. The use of website-based SIMPOL (Polio Immunization Education) media is one of the best alternatives for village midwives in delivering counseling. This greatly assists the government's program in increasing polio immunization coverage. Website-based media has the ability to disseminate information quickly, practically, and easily accessed, making it easier for village midwives to deliver counseling. Thus, the website-based counseling process is believed to increase public awareness to immunize their children. The purpose of this study is to evaluate the effectiveness of the SIMPOL Web-Based Educational Intervention for Village Midwives in Improving Polio Immunization Coverage. Material and Methods: This study employs a quasi-experimental design with a one-group pretest-posttest approach. Results: The mean village-level complete polio immunization coverage increased from 31.05% at baseline to 70.82% following implementation of the SIMPOL web-based educational intervention. This represented a statistically significant increase of 39.78 percentage points (95% CI: 37.58–41.97; t(23) = 37.44, p < 0.001). Conclusion: The SIMPOL web-based educational intervention was associated with a significant improvement in complete polio immunization coverage. Integrating SIMPOL into routine health education delivered by village midwives may strengthen polio immunization programs in primary healthcare settings.
- 5 August 2026
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 5 (2) , 146-155
Open AccessEffectiveness of the SIMPOL Web-Based Educational Intervention for Village Midwives in Improving Polio Immunization Coverage: A Quasi-Experimental Study
Introduction: Polio is a disease caused by the enterovirus (poliovirus) that attacks the brain's nervous system, causing paralysis in children. Although Indonesia has been a polio-free country since 2014, vigilance against the re-emergence of polio virus cases must still be increased by increasing polio immunization coverage. The use of website-based SIMPOL (Polio Immunization Education) media is one of the best alternatives for village midwives in delivering counseling. This greatly assists the government's program in increasing polio immunization coverage. Website-based media has the ability to disseminate information quickly, practically, and easily accessed, making it easier for village midwives to deliver counseling. Thus, the website-based counseling process is believed to increase public awareness to immunize their children. The purpose of this study is to evaluate the effectiveness of the SIMPOL Web-Based Educational Intervention for Village Midwives in Improving Polio Immunization Coverage. Material and Methods: This study employs a quasi-experimental design with a one-group pretest-posttest approach. Results: The mean village-level complete polio immunization coverage increased from 31.05% at baseline to 70.82% following implementation of the SIMPOL web-based educational intervention. This represented a statistically significant increase of 39.78 percentage points (95% CI: 37.58–41.97; t(23) = 37.44, p < 0.001). Conclusion: The SIMPOL web-based educational intervention was associated with a significant improvement in complete polio immunization coverage. Integrating SIMPOL into routine health education delivered by village midwives may strengthen polio immunization programs in primary healthcare settings.
- Open Access
- 1 May 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (3)
5-O-Methylgenistein of Phaleria macrocarpa (Scheff.) Boerl. revealed as a potential therapeutic compound for endometriosis
Context: Endometriosis is a chronic estrogen-dependent inflammatory disorder associated with pelvic pain and infertility. Flavonoids from Phaleria macrocarpa have been reported to exhibit anti-inflammatory activity; however, their molecular mechanisms relevant to endometriosis remain insufficiently characterized. Aims: To predict biological activities of selected P. macrocarpa flavonoids and to explore potential protein–ligand interactions with endometriosis-relevant targets using molecular docking. Methods: Six flavonoids (eriodictyol, glycitin, 5-O-methylgenistein, catechin 7-O-β-D-xyloside, 8-prenylnaringenin, and naringenin) were assessed using the PASS web server to estimate biological activity probabilities (Pa/Pi). The compound with the highest predicted anti-inflammatory probability (Pa > 0.7) was selected for docking against cyclooxygenase-2 (COX-2), estrogen receptor (ER), AKT, aryl hydrocarbon receptor (AHR), and caspase-3 using Molegro Virtual Docker. Docking protocol validation was performed by redocking co-crystallized ligands and evaluating RMSDs. Results: PASS prediction indicated that all compounds exhibited potential anti-inflammatory activity (Pa > Pi), with 5-O-methylgenistein showing the highest confidence prediction (Pa = 0.838). Docking analysis suggested that 5-O-methylgenistein can occupy the binding sites of COX-2, ER, AKT, and AHR, showing comparable interaction patterns and overlapping residues with those of reference ligands, as indicated by software-derived scores. Redocking validation confirmed the acceptable reproduction of the pose (RMSD ≤ 2.0 Å). Conclusions: 5-O-methylgenistein was identified as a promising candidate for further investigation. The predicted interactions support hypotheses related to inflammation- and hormone-associated pathways in endometriosis; however, these findings are based on computational models and require experimental validation to confirm biological activity and therapeutic relevance.
- 1 May 2026
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 14 (3)
Open Access5-O-Methylgenistein of Phaleria macrocarpa (Scheff.) Boerl. revealed as a potential therapeutic compound for endometriosis
Context: Endometriosis is a chronic estrogen-dependent inflammatory disorder associated with pelvic pain and infertility. Flavonoids from Phaleria macrocarpa have been reported to exhibit anti-inflammatory activity; however, their molecular mechanisms relevant to endometriosis remain insufficiently characterized. Aims: To predict biological activities of selected P. macrocarpa flavonoids and to explore potential protein–ligand interactions with endometriosis-relevant targets using molecular docking. Methods: Six flavonoids (eriodictyol, glycitin, 5-O-methylgenistein, catechin 7-O-β-D-xyloside, 8-prenylnaringenin, and naringenin) were assessed using the PASS web server to estimate biological activity probabilities (Pa/Pi). The compound with the highest predicted anti-inflammatory probability (Pa > 0.7) was selected for docking against cyclooxygenase-2 (COX-2), estrogen receptor (ER), AKT, aryl hydrocarbon receptor (AHR), and caspase-3 using Molegro Virtual Docker. Docking protocol validation was performed by redocking co-crystallized ligands and evaluating RMSDs. Results: PASS prediction indicated that all compounds exhibited potential anti-inflammatory activity (Pa > Pi), with 5-O-methylgenistein showing the highest confidence prediction (Pa = 0.838). Docking analysis suggested that 5-O-methylgenistein can occupy the binding sites of COX-2, ER, AKT, and AHR, showing comparable interaction patterns and overlapping residues with those of reference ligands, as indicated by software-derived scores. Redocking validation confirmed the acceptable reproduction of the pose (RMSD ≤ 2.0 Å). Conclusions: 5-O-methylgenistein was identified as a promising candidate for further investigation. The predicted interactions support hypotheses related to inflammation- and hormone-associated pathways in endometriosis; however, these findings are based on computational models and require experimental validation to confirm biological activity and therapeutic relevance.
- Open Access
- 1 April 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (s1) , S140-S152
Network pharmacology and molecular docking of Phaleria macrocarpa (Scheff.) Boerl. bioactive compounds involved in endometriosis pathway
Context: Endometriosis is the presence of endometrial glands and stromal lesions outside the uterus. Aims: To investigate the network pharmacology and molecular docking of Phaleria macrocarpa bioactive compounds on selected endometriosis pathways. Methods: P. macrocarpa compounds were obtained from PubChem. The compounds were analyzed for their potential using the WAY2DRUG PASS prediction. Protein targets were predicted using the Comparative Toxicogenomic Database (CTD), STITCH, and Open Target databases. The pharmacology network analysis was conducted using STRING. Molecular docking analysis was performed between tolfenamic acid, naringenin, eriodictyol, 5-O-methylgenistein, and 8-prenylnaringenin against postaglandin-endoperoxide synthase 2/cyclooxygenase-2 (PTGS2/COX-2) and progesterone receptor (PGR) protein using AutoDock Vina integrated into PyRx v.0.9.8. The visualization was performed using BioVia Discovery Studio 2019 software. Results: For the PTGS/COX-2 pathway, the compounds that have the highest affinity for interaction to occur are tolfenamic acid and naringenin. Against PGR, the phytochemicals with the highest interaction affinity are naringenin and 8-prenylnaringenin. Conclusions: According to the molecular docking results, P. macrocarpa compounds are predicted to have activity as PTGS2/COX-2 inhibitors, especially (±)-naringenin and eriodictyol. Narigenin and 8-prenylnaringenin showed activity to PGR. Compared to 8-prenylnarigenin, naringenin binds more strongly to PGRs.
- 1 April 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (s1) , S140-S152
Open AccessNetwork pharmacology and molecular docking of Phaleria macrocarpa (Scheff.) Boerl. bioactive compounds involved in endometriosis pathway
Context: Endometriosis is the presence of endometrial glands and stromal lesions outside the uterus. Aims: To investigate the network pharmacology and molecular docking of Phaleria macrocarpa bioactive compounds on selected endometriosis pathways. Methods: P. macrocarpa compounds were obtained from PubChem. The compounds were analyzed for their potential using the WAY2DRUG PASS prediction. Protein targets were predicted using the Comparative Toxicogenomic Database (CTD), STITCH, and Open Target databases. The pharmacology network analysis was conducted using STRING. Molecular docking analysis was performed between tolfenamic acid, naringenin, eriodictyol, 5-O-methylgenistein, and 8-prenylnaringenin against postaglandin-endoperoxide synthase 2/cyclooxygenase-2 (PTGS2/COX-2) and progesterone receptor (PGR) protein using AutoDock Vina integrated into PyRx v.0.9.8. The visualization was performed using BioVia Discovery Studio 2019 software. Results: For the PTGS/COX-2 pathway, the compounds that have the highest affinity for interaction to occur are tolfenamic acid and naringenin. Against PGR, the phytochemicals with the highest interaction affinity are naringenin and 8-prenylnaringenin. Conclusions: According to the molecular docking results, P. macrocarpa compounds are predicted to have activity as PTGS2/COX-2 inhibitors, especially (±)-naringenin and eriodictyol. Narigenin and 8-prenylnaringenin showed activity to PGR. Compared to 8-prenylnarigenin, naringenin binds more strongly to PGRs.
- Open Access
- 1 March 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (2) , 527-537
Molecular docking of flavonoids from Phaleria macrocarpa on the NF-kB p65, VEGFR2, Ki67, COX-2, and CXCR4 pathways in endometriosis
Context: Endometriosis is a condition marked by the presence of endometrial epithelium and stromal cells outside the uterus. Previous studies have shown that prostaglandin E2 has a role in the development of endometriosis via the action of local estrogen and estrogen receptors. Aims: To analyze the molecular docking between Phaleria macrocarpa flavonoid compounds in the NF-B, VEGF/VEGFR2, Ki67, COX-2, and CXCR4 pathways that are involved in the pathomechanism of endometriosis. Methods: Functional determination of Phaleria macrocarpa phytochemistry using PASS prediction ADMETSAR's prediction of Phaleria macrocarpa's flavonoids compounds meet the Lipinski rule criteria so that they are predicted to have drug-likeness and no toxicity. Phaleria macrocarpa flavonoids were synthesized using AutoDock Tools 1.5.7 software. AutoDock Vina v1.2.3 software was used to perform docking simulations of ligands and target proteins. The results of the docking analysis were visualized with the Discovery Studio 4.1 application. Results: For the NF-B pathway, the compounds that showed the highest affinity for interaction to occur were (±)-naringenin (target of NF-B p50/p65) and (-)-8-prenylnaringenin (the ATP-binding site in IKK). Against VEGF-A and VEGFR2, the flavonoids that exhibited the highest interaction affinity were glycitin, and (-)-8-prenylnaringenin, respectively. The compound that interacted most easily with Ki67, COX-2, or CXCR4 was (+)-catechin 7-O-beta-D-xyloside. For docking with standard drugs, we found that leuprolide acetate and dienogest showed higher affinity for NF-B p50/p65 heterodimer than flavonoids. Conclusions: The six compounds Phaleria macrocarpa have different affinities for selected pathways in endometriosis. Thus, the Phaleria macrocarpa flavonoids could be a multi-action herbal candidate for endometriosis, which can be used alone or as a complement to standard drugs.
- 1 March 2025
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 13 (2) , 527-537
Open AccessMolecular docking of flavonoids from Phaleria macrocarpa on the NF-kB p65, VEGFR2, Ki67, COX-2, and CXCR4 pathways in endometriosis
Context: Endometriosis is a condition marked by the presence of endometrial epithelium and stromal cells outside the uterus. Previous studies have shown that prostaglandin E2 has a role in the development of endometriosis via the action of local estrogen and estrogen receptors. Aims: To analyze the molecular docking between Phaleria macrocarpa flavonoid compounds in the NF-B, VEGF/VEGFR2, Ki67, COX-2, and CXCR4 pathways that are involved in the pathomechanism of endometriosis. Methods: Functional determination of Phaleria macrocarpa phytochemistry using PASS prediction ADMETSAR's prediction of Phaleria macrocarpa's flavonoids compounds meet the Lipinski rule criteria so that they are predicted to have drug-likeness and no toxicity. Phaleria macrocarpa flavonoids were synthesized using AutoDock Tools 1.5.7 software. AutoDock Vina v1.2.3 software was used to perform docking simulations of ligands and target proteins. The results of the docking analysis were visualized with the Discovery Studio 4.1 application. Results: For the NF-B pathway, the compounds that showed the highest affinity for interaction to occur were (±)-naringenin (target of NF-B p50/p65) and (-)-8-prenylnaringenin (the ATP-binding site in IKK). Against VEGF-A and VEGFR2, the flavonoids that exhibited the highest interaction affinity were glycitin, and (-)-8-prenylnaringenin, respectively. The compound that interacted most easily with Ki67, COX-2, or CXCR4 was (+)-catechin 7-O-beta-D-xyloside. For docking with standard drugs, we found that leuprolide acetate and dienogest showed higher affinity for NF-B p50/p65 heterodimer than flavonoids. Conclusions: The six compounds Phaleria macrocarpa have different affinities for selected pathways in endometriosis. Thus, the Phaleria macrocarpa flavonoids could be a multi-action herbal candidate for endometriosis, which can be used alone or as a complement to standard drugs.
- Open Access
- 10 April 2024
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 3 (1) , 94-98
Literature Review: Relationship of Lifestyle with Incidence of Primary Dysmenorrhea in College Students
Introduction: Menstruation is periodic and cyclic bleeding from the uterus, accompanied by endometrial desquamation. In specific individuals, menstruation can cause pain called dysmenorrhea, which is characterized by mild, moderate, and severe menstrual pain. Primary dysmenorrhea is not a life-threatening disorder, but it can hurt women's quality of life. Prevalence of menopause in Indonesia An estimated 55% of women of reproductive age experience pain during menstruation. Material and Methods: We searched articles published from 2014-2020 in PubMed, Proquest, and Google Scholar with the keywords "primary dysmenorrhea” AND “student lifestyle”. All data were gathered and analyzed. Results: The results showed that 8 articles showed the relationship between lifestyle and the occurrence of primary menstrual pain among female students. In comparison, the other two articles show that there is no relationship between lifestyle and primary dysmenorrhea in female students. Conclusion: This study concludes that an unhealthy lifestyle, such as high stress levels, infrequent exercise, and frequent consumption of fast food, is effective for primary dysmenorrhea during menstruation.
- 10 April 2024
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 3 (1) , 94-98
Open AccessLiterature Review: Relationship of Lifestyle with Incidence of Primary Dysmenorrhea in College Students
Introduction: Menstruation is periodic and cyclic bleeding from the uterus, accompanied by endometrial desquamation. In specific individuals, menstruation can cause pain called dysmenorrhea, which is characterized by mild, moderate, and severe menstrual pain. Primary dysmenorrhea is not a life-threatening disorder, but it can hurt women's quality of life. Prevalence of menopause in Indonesia An estimated 55% of women of reproductive age experience pain during menstruation. Material and Methods: We searched articles published from 2014-2020 in PubMed, Proquest, and Google Scholar with the keywords "primary dysmenorrhea” AND “student lifestyle”. All data were gathered and analyzed. Results: The results showed that 8 articles showed the relationship between lifestyle and the occurrence of primary menstrual pain among female students. In comparison, the other two articles show that there is no relationship between lifestyle and primary dysmenorrhea in female students. Conclusion: This study concludes that an unhealthy lifestyle, such as high stress levels, infrequent exercise, and frequent consumption of fast food, is effective for primary dysmenorrhea during menstruation.
- Open Access
- 24 January 2024
- Published by Wiley in The Scientific World Journal
- Vol. 2024, 1-7
Genistein Ameliorated Vascular Endothelial Growth Factor-A (VEGF-A) and Estrogen Receptor-Alpha (ER-α) in Endometriosis Mice Model, In Vivo and In Silico
Endometriosis (EM) is a gynecological disorder that causes morbidity in women and is characterized by endometrial tissue in the uterus cavity. This study investigated the mechanism of genistein in the VEGF-A and ER-α expression through in vivo and in silico approaches. An in vivo study was conducted by thirty-six mice that were divided into six groups including control, EM, and EM treatment with genistein with the doses of 1.3, 1.95, 2.6, and 3.25 mg/day for 14 days. Peritoneal tissues with lesions were collected and analyzed by immunohistochemistry to measure the VEGF-A and ER-α expression. The data were analyzed using a statistical approach using one-way ANOVA followed by Tukey HSD test with a significant value . In silico study was conducted for investigating the inhibition mechanism of genistein in VEGF-A and ER-α protein. Genistein significantly reduced the VEGF-A and ER-α expression with the optimum dose of 3.25 mg/day. Molecular docking showed that genistein inhibited VEGF-A in several active site residues of VEGF-A, also blocked the ER-α protein in estradiol binding sites. This study concluded that genistein prevented endometriosis by performing the antiangiogenic activity and showed a similar function to estradiol.
- 24 January 2024
- Published by Wiley in The Scientific World Journal
- Vol. 2024, 1-7
Open AccessGenistein Ameliorated Vascular Endothelial Growth Factor-A (VEGF-A) and Estrogen Receptor-Alpha (ER-α) in Endometriosis Mice Model, In Vivo and In Silico
Endometriosis (EM) is a gynecological disorder that causes morbidity in women and is characterized by endometrial tissue in the uterus cavity. This study investigated the mechanism of genistein in the VEGF-A and ER-α expression through in vivo and in silico approaches. An in vivo study was conducted by thirty-six mice that were divided into six groups including control, EM, and EM treatment with genistein with the doses of 1.3, 1.95, 2.6, and 3.25 mg/day for 14 days. Peritoneal tissues with lesions were collected and analyzed by immunohistochemistry to measure the VEGF-A and ER-α expression. The data were analyzed using a statistical approach using one-way ANOVA followed by Tukey HSD test with a significant value . In silico study was conducted for investigating the inhibition mechanism of genistein in VEGF-A and ER-α protein. Genistein significantly reduced the VEGF-A and ER-α expression with the optimum dose of 3.25 mg/day. Molecular docking showed that genistein inhibited VEGF-A in several active site residues of VEGF-A, also blocked the ER-α protein in estradiol binding sites. This study concluded that genistein prevented endometriosis by performing the antiangiogenic activity and showed a similar function to estradiol.
- Open Access
- 15 December 2023
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 2 (3) , 38-42
Relationship between Age and Pregnancy Distance with the Incidence of Miscarriage at the Sabang City Regional General Hospital
Introduction: Pregnant women who experience miscarriage may experience health complications that lead to maternal morbidity or death. The incidence of miscarriage rose by 26% in women over 40 years old and by 12% in women under the age of 20. Due to their immature uteri, pregnant women under the age of twenty are particularly vulnerable to complications during pregnancy and childbirth, including miscarriage. In addition, women over 35 may be more susceptible to issues with their aging uterine organs, which raises the possibility of chromosomal abnormalities and pregnancy. Material and Methods: This type of research is an analytic survey with a cross-sectional approach. This research was conducted in the Sabang City Regional General Hospital in May 2022. The population in this study was 320 people, while the sampling technique was total sampling. Results: Test analysis of research results using the chi-square test. Based on the results of the study show a relationship between age and the incidence of miscarriage with a value of p = 0.000 < 0.05, and there is a relationship between pregnancy distance and the incidence of miscarriage with a value of p = 0.000 < 0.05. Conclusion: There is a relationship between age and pregnancy distance to the incidence of miscarriage.
- 15 December 2023
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 2 (3) , 38-42
Open AccessRelationship between Age and Pregnancy Distance with the Incidence of Miscarriage at the Sabang City Regional General Hospital
Introduction: Pregnant women who experience miscarriage may experience health complications that lead to maternal morbidity or death. The incidence of miscarriage rose by 26% in women over 40 years old and by 12% in women under the age of 20. Due to their immature uteri, pregnant women under the age of twenty are particularly vulnerable to complications during pregnancy and childbirth, including miscarriage. In addition, women over 35 may be more susceptible to issues with their aging uterine organs, which raises the possibility of chromosomal abnormalities and pregnancy. Material and Methods: This type of research is an analytic survey with a cross-sectional approach. This research was conducted in the Sabang City Regional General Hospital in May 2022. The population in this study was 320 people, while the sampling technique was total sampling. Results: Test analysis of research results using the chi-square test. Based on the results of the study show a relationship between age and the incidence of miscarriage with a value of p = 0.000 < 0.05, and there is a relationship between pregnancy distance and the incidence of miscarriage with a value of p = 0.000 < 0.05. Conclusion: There is a relationship between age and pregnancy distance to the incidence of miscarriage.
- Open Access
- 11 August 2023
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 2 (2) , 36-41
Hepatotoxicity Oral Administration of Flavonoids Rich Extract from Phaleria Macrocarpha in Mice
Introduction : Herbal medications are increasingly being used to treat a wide range of illnesses. Phaleria macrocarpa, often known as the crown of the gods, is a plant rich in flavonoids that is frequently used in herbal therapy. The goal of this study was to see what effect a flavonoid-rich extract from phaleria macrocarpa has on the livers of mice. Material and Methode : This study used adult female mice aged 6-8 weeks and weighing 20-30 gr as experimental animals, which were divided into four groups: the control group was given distilled water, group 2 was given a flavonoid dose of 500 mg/kg/day, group 3 was given a flavonoid dose of 1000 mg/kg/day, and group 4 was given a flavonoid dose of 2000 mg/kg/day. The flavonoid-rich extract of Phaleria macrocarpa was administered for 28 days. On the 29th day, the mice were necropsied, followed by surgery and examination of the mice's livers. Result : The flavonoid-rich extract of phaleria macrocarpa at a dose of 500 mg/kg body weight/day resulted in no changes in the weight or histological structure of the liver (p>0.05). Hydropic degeneration and necrosis were observed in the group administered the flavonoid-rich extract of phaleria macrocarpa at doses of 1000 and 2000 mg/kg body weight/day. Conclusion : The administration of a flavonoid-rich extract from Phaleria macrocarpa at a level of 500 mg/kg body weight/day caused no harm in the liver of mice. The use of more than 500 mg/kg body weight/day over an extended period of time has hazardous effects and is not recommended.
- 11 August 2023
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 2 (2) , 36-41
Open AccessHepatotoxicity Oral Administration of Flavonoids Rich Extract from Phaleria Macrocarpha in Mice
Introduction : Herbal medications are increasingly being used to treat a wide range of illnesses. Phaleria macrocarpa, often known as the crown of the gods, is a plant rich in flavonoids that is frequently used in herbal therapy. The goal of this study was to see what effect a flavonoid-rich extract from phaleria macrocarpa has on the livers of mice. Material and Methode : This study used adult female mice aged 6-8 weeks and weighing 20-30 gr as experimental animals, which were divided into four groups: the control group was given distilled water, group 2 was given a flavonoid dose of 500 mg/kg/day, group 3 was given a flavonoid dose of 1000 mg/kg/day, and group 4 was given a flavonoid dose of 2000 mg/kg/day. The flavonoid-rich extract of Phaleria macrocarpa was administered for 28 days. On the 29th day, the mice were necropsied, followed by surgery and examination of the mice's livers. Result : The flavonoid-rich extract of phaleria macrocarpa at a dose of 500 mg/kg body weight/day resulted in no changes in the weight or histological structure of the liver (p>0.05). Hydropic degeneration and necrosis were observed in the group administered the flavonoid-rich extract of phaleria macrocarpa at doses of 1000 and 2000 mg/kg body weight/day. Conclusion : The administration of a flavonoid-rich extract from Phaleria macrocarpa at a level of 500 mg/kg body weight/day caused no harm in the liver of mice. The use of more than 500 mg/kg body weight/day over an extended period of time has hazardous effects and is not recommended.
- Open Access
- 11 August 2023
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 2 (2) , 3-9
Comparison of the Effects of Dienogest and Leuprolide Acetat on Serum Interferon (IFN-Ɣ) Levels in a Mouse Model of Endometriosis (Mus musculus)
Introduction: Endometriosis is a medical condition in which there is abnormal growth of tissue resembling the endometrium outside the uterus. It can cause symptoms of pain and/or infertility. The current medical therapy focuses on reducing estradiol levels or stimulating progesterone response. One of the most effective options for medical treatment is the use of GnRH analogs. Dienogest have a direct anti-inflammatory effect on endometriotic stromal cells. However, a comparison of the anti-inflammatory effects of these drugs on IFN-Ɣ has not been previously investigated. Therefore, this study aims to compare the effects of reducing IFN-Ɣ by both Dienogest and Leuprolide Acetat in a mouse model. Material and Methods: This study employed a post-test only control group design and involved 4 groups, namely the negative control group, positive control group, and two treatment groups: one group administered Dienogest at a dosage of 0.0052 milligrams per day for 14 days, and the other administered Leuprolide Acetat at a dosage of 0.00975 milligrams once every 5 days for a period of 14 days. Serum IFN-Ɣ levels were measured using Enzyme-Linked Immunosorbent Assay (ELISA). The data were subsequently analyzed using IBM SPSS 25 with One-Way ANOVA test. Results: This study demonstrated that Leuprolide Acetat significantly decreased serum levels of IFN-Ɣ, whereas Dienogest actually increased the levels . Conclusion: In a mouse model of endometriosis (Mus musculus), Leuprolide Acetat effectively reduced the levels of IFN-Ɣ (pro-inflammatory). Conversely, Dienogest increased the levels of IFN-Ɣ (anti-inflammatory) in the mouse model of endometriosis.
- 11 August 2023
- Published by Ikatan Dokter Indonesia Wilayah Jawa Timur in Asian Journal of Health Research
- Vol. 2 (2) , 3-9
Open AccessComparison of the Effects of Dienogest and Leuprolide Acetat on Serum Interferon (IFN-Ɣ) Levels in a Mouse Model of Endometriosis (Mus musculus)
Introduction: Endometriosis is a medical condition in which there is abnormal growth of tissue resembling the endometrium outside the uterus. It can cause symptoms of pain and/or infertility. The current medical therapy focuses on reducing estradiol levels or stimulating progesterone response. One of the most effective options for medical treatment is the use of GnRH analogs. Dienogest have a direct anti-inflammatory effect on endometriotic stromal cells. However, a comparison of the anti-inflammatory effects of these drugs on IFN-Ɣ has not been previously investigated. Therefore, this study aims to compare the effects of reducing IFN-Ɣ by both Dienogest and Leuprolide Acetat in a mouse model. Material and Methods: This study employed a post-test only control group design and involved 4 groups, namely the negative control group, positive control group, and two treatment groups: one group administered Dienogest at a dosage of 0.0052 milligrams per day for 14 days, and the other administered Leuprolide Acetat at a dosage of 0.00975 milligrams once every 5 days for a period of 14 days. Serum IFN-Ɣ levels were measured using Enzyme-Linked Immunosorbent Assay (ELISA). The data were subsequently analyzed using IBM SPSS 25 with One-Way ANOVA test. Results: This study demonstrated that Leuprolide Acetat significantly decreased serum levels of IFN-Ɣ, whereas Dienogest actually increased the levels . Conclusion: In a mouse model of endometriosis (Mus musculus), Leuprolide Acetat effectively reduced the levels of IFN-Ɣ (pro-inflammatory). Conversely, Dienogest increased the levels of IFN-Ɣ (anti-inflammatory) in the mouse model of endometriosis.
- Open Access
- 31 January 2023
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 12 (1) , 5582-5587
Phaleria macrocarpa for Endometriosis Treatment: A Review
Around 5—10% women in their productive age could suffer from endometriosis, a condition where viable endometrial tissue is present outside the uterine cavity. This disease could progress into ovarian cancer and infertility with long-lasting chronic pain. Thus, innovation for safe and efficacious management of this disease is urgent. Exploring the abilities of medicinal plants for endometriosis therapy is quite promising. Of which, Phaleria macrocarpa has been suggested as a strong candidate for the therapy. This review begins with explanations of endometriosis; its aetiology and pathobiology. Thereafter, we present the medicinal properties of P. macrocarpa for being anti-inflammatory, anti-angiogenesis, and anti-proliferation. Results from pre-clinical studies and an ongoing trial of P. macrocarpa as a therapy for endometriosis were also discussed in this review. Future study will explore the activity of this plant extracts against hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), B-cell lymphoma 2 (Bcl-2), and Bcl-2-associated X protein (BAX).
- 31 January 2023
- Published by Medic Scientific in Journal of Medical pharmaceutical and allied sciences
- Vol. 12 (1) , 5582-5587
Open AccessPhaleria macrocarpa for Endometriosis Treatment: A Review
Around 5—10% women in their productive age could suffer from endometriosis, a condition where viable endometrial tissue is present outside the uterine cavity. This disease could progress into ovarian cancer and infertility with long-lasting chronic pain. Thus, innovation for safe and efficacious management of this disease is urgent. Exploring the abilities of medicinal plants for endometriosis therapy is quite promising. Of which, Phaleria macrocarpa has been suggested as a strong candidate for the therapy. This review begins with explanations of endometriosis; its aetiology and pathobiology. Thereafter, we present the medicinal properties of P. macrocarpa for being anti-inflammatory, anti-angiogenesis, and anti-proliferation. Results from pre-clinical studies and an ongoing trial of P. macrocarpa as a therapy for endometriosis were also discussed in this review. Future study will explore the activity of this plant extracts against hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), B-cell lymphoma 2 (Bcl-2), and Bcl-2-associated X protein (BAX).